DR

Diabetes-metabolism Research And Reviews

Diabetes/Metabolism Research and Reviews is an endocrinology and metabolism journal read by clinicians and researchers. It covers all areas of diabetes, endocrinology, metabolism and obesity, and welcomes clinical studies, basical and translational research, and reviews of historical progress, controversial issues and prominent opinions.

Looking to publish in Diabetes-metabolism Research And Reviews? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Endocrinology & Metabolism
Impact Factor 6
Quartile Q1
Open Access Type Hybrid
ISSN 1520-7552
eISSN 1520-7560
Invitation Only No
Cost Range Special discounted subscription rates are offered to society members.

Submission Instructions

Diabetes-metabolism Research And Reviews accepts the following article types. Click on an article type to view submission instructions.

Research Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required for Research Articles. Abstract must not exceed 250 words. Abstract must be structured. Abstract must use the headings aims, materials and methods, results, and conclusions.
Manuscript Main text should be 3,500 words excluding references, tables, figures, and legends. Manuscript must be organized as introduction, materials and methods, results, discussion, acknowledgements, references, legends to figures, tables, and figures. Title page must include author names, full affiliations, a short running title, and the word counts for the abstract and main text plus the numbers of references, tables, and figures.
References References must be numbered consecutively in order of appearance and cited in the text using Arabic superscript numerals.
Figures & Tables A maximum of 5 figures and/or tables is permitted. Figures must be supplied as separate files.
Reformat to Diabetes-metabolism Research And Reviews using Livewrite Premium

Review Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must be up to 250 words. Abstract does not need to be structured.
Manuscript Review articles have no set word limit. Manuscript text should be presented in the order Title, Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgements, and References. Authors are encouraged to provide up to six keywords in a Keywords section.
References References must be numbered consecutively in order of appearance and cited in the text using Arabic superscript numerals, with journal title abbreviations conforming to Chemical Abstracts practice.
Figures & Tables Figures must be supplied as separate files from the main manuscript. Figures should be numbered in the order cited in the text, and tables should be supplied as editable files rather than pasted as images.
Reformat to Diabetes-metabolism Research And Reviews using Livewrite Premium

Commentaries

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is not required for Commentaries.
Manuscript Commentaries are generally limited to 1,500 words.
References Commentaries are generally limited to 15 references. References must be numbered consecutively in order of appearance and cited in the text using Arabic superscript numerals.
Figures & Tables Figures must be supplied as separate files from the main manuscript.
Reformat to Diabetes-metabolism Research And Reviews using Livewrite Premium

Recent Publications

Compensated But Failing: Early β‐Cell Dysfunction Under Normoglycemia in Children and Adolescents With Overweight and Obesity

Paulina Correa‐Burrows, Estela Blanco, Raquel Burrows

10.1002/dmrr.70172
View Publication

Issue Information

-

10.1002/dmrr.70166
View Publication

Not All GLP‐1 Receptor Agonists Are Alike: Real‐World Evidence of Differential Endocrine and Dermatologic Safety

Nai Lee, Yun Kim

10.1002/dmrr.70163
View Publication

Reassessment of the Diagnostic Accuracy of HbA 1c and Glucose for Type 2 Diabetes: A Systematic Review and Meta‐Analysis of Observational Studies

Christina Baechle, Ferdinand V. Stoye, Nafiseh Shokri‐Mashhadi, Anna‐Therese Klötzsch, Brenda Bongaerts, Annika Hoyer, Oliver Kuss, Rüdiger Landgraf, Wolfgang Rathmann, Sabrina Schlesinger

10.1002/dmrr.70160
View Publication

Global Trends and Inequalities in Diabetes Prevalence and Treatment Coverage Among Adults Aged ≥ 45 Years, 1990–2040: Insights From the NCD‐RisC Database

Jinli Liu, Yanan Wang, Lei Zhang, Shaonong Dang

10.1002/dmrr.70164
View Publication

Frequently asked questions

How long does it take to publish?

What are the publication costs?

Hybrid journal. Open Access APC stated as $5,020 USD / £3,290 GBP / €4,180 EUR; another APC amount is also listed as $4,330 USD / £2,840 GBP / €3,610 EUR.

Reformat to Diabetes-metabolism Research And Reviews using Livewrite Premium

Research Topics

Diabetes Management and Research Diabetes and associated disorders Pancreatic function and diabetes Diabetes Treatment and Management Diabetes, Cardiovascular Risks, and Lipoproteins Metabolism, Diabetes, and Cancer Diabetic Foot Ulcer Assessment and Management Diet and metabolism studies Wound Healing and Treatments Adipokines, Inflammation, and Metabolic Diseases Gestational Diabetes Research and Management Peroxisome Proliferator-Activated Receptors Diet, Metabolism, and Disease Liver Disease Diagnosis and Treatment Pressure Ulcer Prevention and Management Human auditory perception and evaluation Educational Robotics and Engineering Adipose Tissue and Metabolism Advanced Glycation End Products research Diverse Scientific and Economic Studies Diabetes Management and Education Cardiovascular Function and Risk Factors Hyperglycemia and glycemic control in critically ill and hospitalized patients Chronic Kidney Disease and Diabetes Pain Mechanisms and Treatments

Related Journals

Bi
Biofactors WILEY
Di
Diabetes American Diabetes Association
JO
Journal Of Esthetic And Restorative Dentistry WILEY
OI
Osteoporosis International Springer Science+Business Media
JO
Journal Of Obesity & Metabolic Syndrome Korean Society for the Study of Obesity
DT
Diabetes Technology & Therapeutics Mary Ann Liebert, Inc.